ACTUATE THERAPEUTICS Share Price Today: Live Updates & Key Insights
ACTUATE THERAPEUTICS share price today is $2.335, up -6%. The stock opened at $2.64 against the previous close of $2.5, with an intraday high of $2.64 and low of $2.305.
ACTUATE THERAPEUTICS Share Price Chart
ACTUATE THERAPEUTICS
ACTUATE THERAPEUTICS Share Price Performance
ACTUATE THERAPEUTICS Institutional Holdings
ACTUATE THERAPEUTICS Market Status
ACTUATE THERAPEUTICS Fundamentals
Market Cap 136.67 M
PB Ratio 5.3346
PE Ratio 0.0
Enterprise Value 64.66 M
Total Assets 9.32 M
Volume 123666
ACTUATE THERAPEUTICS Company Financials
About ACTUATE THERAPEUTICS & investment objective
Company Information Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States. The company's lead product candidate is elraglusib injection, a glycogen synthase kinase-3 inhibitor that is in Phase 2 trial to treat metastatic pancreatic ductal adenocarcinoma. It also develops elraglusib, which is in Phase 1/2 trial for the treatment of refractory pediatric malignancies, including Ewing sarcoma, as well as metastatic melanoma and colorectal cancer. The company was formerly known as Apotheca Therapeutics, Inc. and changed its name to Actuate Therapeutics, Inc. in October 2015. Actuate Therapeutics, Inc. was incorporated in 2015 and is headquartered in Fort Worth, Texas.
Organisation Biotechnology
Employees 10
Industry Biotechnology
CEO Mr. Daniel M. Schmitt
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
ACTUATE THERAPEUTICS FAQs
What is the share price of ACTUATE THERAPEUTICS today?
The current share price of ACTUATE THERAPEUTICS is $2.335.
Can I buy ACTUATE THERAPEUTICS shares in India?
Yes, Indian investors can buy ACTUATE THERAPEUTICS shares by opening an international trading and demat account with Motilal Oswal.
How to buy ACTUATE THERAPEUTICS shares in India?
You can easily invest in ACTUATE THERAPEUTICS shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy ACTUATE THERAPEUTICS shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of ACTUATE THERAPEUTICS.
Can I buy fractional shares of ACTUATE THERAPEUTICS?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of ACTUATE THERAPEUTICS?
ACTUATE THERAPEUTICS has a market cap of $136.67 M.
In which sector does ACTUATE THERAPEUTICS belong?
ACTUATE THERAPEUTICS operates in the Biotechnology sector.
What documents are required to invest in ACTUATE THERAPEUTICS stocks?
To invest, you typically need:
What is the PE and PB ratio of ACTUATE THERAPEUTICS?
The PE ratio of ACTUATE THERAPEUTICS is N/A and the PB ratio is 5.33.